BrazilData Updated on May 09, 2026871K
96.73M
$960
Since Jan 01, 2026
Ready for YouTube growth?
Take your views to the next level with keyword insights, video ideas, and even more growth tools from vidIQ.
Since Jan 01, 2026
Ready for YouTube growth?
Take your views to the next level with keyword insights, video ideas, and even more growth tools from vidIQ.
Dragon Pharma Brasil's top videos since Oct 11, 2016
| Videos | Total views | VPH | Outlier score | |
|---|---|---|---|---|
| 950.22K | 6.2 | >100x | ||
| 938.33K | 0.4 | >100x | ||
| 787.9K | 0.6 | >100x | ||
| 731.33K | 0.7 | 98.35x | ||
| 698K | 4 | — |
BR#4,730See stats without leaving YouTube
Get instant access to subscriber counts, views, and growth trends directly on the YouTube channel pages.
Dragon Pharma Brasil's top videos since Oct 11, 2016
| Videos | Total views | VPH | Outlier score | |
|---|---|---|---|---|
| 950.22K | 6.2 | >100x | ||
| 938.33K | 0.4 | >100x | ||
| 787.9K | 0.6 | >100x | ||
| 731.33K | 0.7 | 98.35x | ||
| 698K | 4 | — |
Based on current CPM estimates, Dragon Pharma Brasil YouTube AdSense earnings are estimated at $959.69 monthly.
Dragon Pharma Brasil is currently ranked #77,311 on YouTube.
Dragon Pharma Brasil gained 4K subscribers in the last 30 days.
Dragon Pharma Brasil got 616.41K views in the last 30 days.
Dragon Pharma Brasil started their YouTube channel on October 11, 2016.
Dragon Pharma Brasil is based in Brazil.
Dragon Pharma Brasil makes an estimated $120 per video based on their recent upload frequency and recent estimated CPMs
Based on current CPM estimates, Dragon Pharma Brasil YouTube AdSense earnings are estimated at $959.69 monthly.
Dragon Pharma Brasil is currently ranked #77,311 on YouTube.
Dragon Pharma Brasil gained 4K subscribers in the last 30 days.
Dragon Pharma Brasil got 616.41K views in the last 30 days.
Dragon Pharma Brasil started their YouTube channel on October 11, 2016.
Dragon Pharma Brasil is based in Brazil.
Dragon Pharma Brasil makes an estimated $120 per video based on their recent upload frequency and recent estimated CPMs
